A clinical trial with live attenuated rubella virus vaccine (Cendehill 51 strain).
D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000032:analysis; D001831:Body Temperature; D002648:Child; D002986:Clinical Trials as Topic; D003139:Common Cold / Q000209:etiology; D003231:Conjunctivitis / Q000209:etiology; D005076:Exanthema / Q000209:etiology; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D008206:Lymphatic Diseases / Q000209:etiology; D008297:Male; D009500:Neutralization Tests; D009666:Nose / Q000382:microbiology; D010612:Pharyngitis / Q000209:etiology; D010614:Pharynx / Q000382:microbiology; D012411:Rubella Vaccine; D012412:Rubella virus / Q000302:isolation & purification; D014069:Tonsillitis / Q000209:etiology; D014611:Vaccination; D014765:Viral Vaccines; D014776:Virus Cultivation
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines